RecruitingNot ApplicableNCT07071506

New Methods for Evaluating Preventive Migraine Treatment

Sponsor

University of Aarhus

Enrollment

60 participants

Start Date

Jun 19, 2025

Study Type

INTERVENTIONAL

Conditions

Migraine Headache Disorders Chronic Migraine, Headache Migraine With or Without Aura

Summary

The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatment information provided. Using a clinical within-subjects, balanced placebo design, patients with chronic migraine will receive four treatment conditions in a randomized order.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Active drug for chronic migraine treatment. and a drug called Placebo Subcutaneous injection for people with chronic migraine, headache, headache disorders, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.